We are live on ! Find out more
DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $59.2B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+9.53%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$6.09B
AUM Growth
+$393M
Cap. Flow
-$95.1M
Cap. Flow %
-1.56%
Top 10 Hldgs %
33.43%
Holding
956
New
52
Increased
378
Reduced
294
Closed
42

Top Buys

Rank Stock Value
1
LAZ icon
Lazard
LAZ
+$10.7M
2
QGENF
QIAGEN NV
QGENF
+$8.34M
3
CSCO icon
Cisco
CSCO
+$8.11M
4
FRC
First Republic Bank
FRC
+$7.27M
5
PSX icon
Phillips 66
PSX
+$6.75M

Top Sells

Rank Stock Value
1
DB icon
Deutsche Bank
DB
+$39M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$11.6M
3
TGT icon
Target
TGT
+$10.9M
4
GE icon
GE Aerospace
GE
+$10.3M
5
PNC icon
PNC Financial Services
PNC
+$8.52M

Sector Composition

Rank Sector Weight
1 Financials 29.83%
2 Healthcare 16%
3 Technology 10.83%
4 Communication Services 9.48%
5 Industrials 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GIL icon
501
Gildan
GIL
$10.6B
$688K 0.01%
25,694
+8,894
+53% +$217K
SRE icon
502
Sempra
SRE
$54.8B
$685K 0.01%
15,358
– –
HDB icon
503
HDFC Bank
HDB
$121B
$678K 0.01%
78,000
+6,800
+10% +$57.9K
PDLI
504
DELISTED
PDL BioPharma, Inc.
PDLI
$677K 0.01%
79,900
+1,500
+2% +$12.6K
UHS icon
505
Universal Health Services
UHS
$10.5B
$670K 0.01%
+8,350
New +$667K
ACOR
506
DELISTED
Acorda Therapeutics
ACOR
$670K 0.01%
193
+4
+2% +$15.6K
HSP
507
DELISTED
HOSPIRA INC
HSP
$667K 0.01%
16,205
-300
-2% -$12.1K
AIT icon
508
Applied Industrial Technologies
AIT
$13.3B
$664K 0.01%
13,500
– –
AYI icon
509
Acuity Brands
AYI
$10.8B
$658K 0.01%
6,000
+2,450
+69% +$250K
CSTE icon
510
Caesarstone
CSTE
$79.5M
$650K 0.01%
+13,500
New +$613K
IRWD icon
511
Ironwood Pharmaceuticals
IRWD
$714M
$650K 0.01%
64,954
+2,985
+5% +$26.8K
RNR icon
512
RenaissanceRe
RNR
$13.4B
$647K 0.01%
6,811
+6,500
+2,090% +$605K
AVY icon
513
Avery Dennison
AVY
$13.4B
$646K 0.01%
12,806
+12,200
+2,013% +$574K
MKC icon
514
McCormick & Company Non-Voting
MKC
$14.2B
$637K 0.01%
18,518
-19,840
-52% -$677K
TGT icon
515
Target
TGT
$68B
$629K 0.01%
10,098
-171,276
-94% -$10.9M
EXEL icon
516
Exelixis
EXEL
$13.4B
$625K 0.01%
105,000
+2,500
+2% +$13.8K
LGND icon
517
Ligand Pharmaceuticals
LGND
$6.36B
$623K 0.01%
18,595
+481
+3% +$15.7K
PCYC
518
DELISTED
PHARMACYCLICS INC
PCYC
$620K 0.01%
+5,900
New +$716K
NVAX icon
519
Novavax
NVAX
$1.31B
$614K 0.01%
5,950
+1,265
+27% +$89.4K
UNFI icon
520
United Natural Foods
UNFI
$2.85B
$612K 0.01%
8,100
– –
VSH icon
521
Vishay Intertechnology
VSH
$5.43B
$611K 0.01%
46,200
-13,700
-23% -$174K
CHK
522
DELISTED
Chesapeake Energy Corporation
CHK
$606K 0.01%
116
+21
+22% +$107K
WPM icon
523
Wheaton Precious Metals
WPM
$60.9B
$599K 0.01%
30,000
-49,800
-62% -$1.08M
BRKR icon
524
Bruker
BRKR
$8.14B
$596K 0.01%
+30,000
New +$588K
PNW icon
525
Pinnacle West Capital
PNW
$12.2B
$590K 0.01%
11,100
– –
19 20
21
22 23

Similar funds

Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Aviva
Aviva London, United Kingdom $59.6B AUM 28.44% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

DekaBank Deutsche Girozentrale's Q4 2013 Portfolio in Review

As of Q4 2013, DekaBank Deutsche Girozentrale held 956 positions worth $6.09B, up 6.9% from $5.69B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

DekaBank Deutsche Girozentrale's Q4 2013 filing shows 52 new, 378 increased, 294 reduced and 42 closed positions. Its largest new stake was Lazard: 264,565 shares worth $11.9M. The largest sale was Deutsche Bank, an estimated $39M.

By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Technology.

  • DekaBank Deutsche Girozentrale's largest Q4 2013 buy was Lazard: 264,565 shares worth $11.9M.
  • DekaBank Deutsche Girozentrale added most to QIAGEN NV in Q4 2013, an estimated $8.34M increase.
  • DekaBank Deutsche Girozentrale's biggest Q4 2013 reduction was Deutsche Bank, cutting an estimated $39M.
  • DekaBank Deutsche Girozentrale fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $5.92M.
  • DekaBank Deutsche Girozentrale's ten largest holdings make up 33% of its $6.09B portfolio in Q4 2013.
  • DekaBank Deutsche Girozentrale opened 52 new positions and closed 42 in Q4 2013.
  • DekaBank Deutsche Girozentrale's portfolio value rose 6.9% quarter-over-quarter to $6.09B.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2013, filed 11 Feb 2014.